Drugs / Fluzopril
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06102707 | Nov 2023 → Nov 2025 overdue | ovarian carcinoma | Qilu Hospital of Shandong University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluzopril | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06102707 ↗ |
| Route | Oral | “Fluzopril Capsules 100mg po bid” NCT06102707 ↗ |